AbbVie Drops Court Bid to Block Clinical-Trial Data Release
This article is for subscribers only.
AbbVie Inc. dropped its court challenge to the European Medicines Agency, paving the way for the release of clinical-trial data from the company.
AbbVie said it decided to withdraw its lawsuits at the European Union General Court, the bloc’s second-highest tribunal, after the EMA accepted redacted documents from the company and also its “rationale for removing certain commercially confidential information from the clinical study reports that are at the center of the litigation.”